Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR LigandsHongyi Zhao, San‐Qi Zhang, Xiao-Xiao Xi et al.|Journal of Medicinal Chemistry|2022Cited by 74